YPS

Ypsomed Hldg

Stock
Stock
ISIN: CH0019396990
Ticker: YPSN
CH0019396990
YPSN

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Ypsomed Hldg has so far distributed $5.442 in 2026. The next dividend will be paid on 07.07.2027


$1.452

CHART BY

Frequently asked questions

The market capitalization of Ypsomed Hldg is 4.61B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Ypsomed Hldg is 23.31. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Ypsomed Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $16.31. EPS indicates the company's profitability on a per-share basis.
Currently, 12 analysts cover Ypsomed Hldg's stock, with a consensus target price of 404.82. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Ypsomed Hldg reported a revenue of 730.98M.
Ypsomed Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 266.89M. EBITDA measures the company's overall financial performance.
Ypsomed Hldg has a free cash flow of 11.18M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Ypsomed Hldg employs approximately 2,025 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Ypsomed Hldg is 2.46M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
4.61B
EPS (TTM) 
$16.31
Free Float 
2.46M
P/E ratio (TTM) 
23.31
Revenue (TTM) 
730.98M
EBITDA (TTM) 
266.89M
Free Cashflow (TTM) 
11.18M

Pricing

1D span
$432.31$470.44
52W span
$334.56$529.32

Analyst Ratings

The price target is 404.82 and the stock is covered by 12 analysts.

Buy

7

Hold

4

Sell

1

Information

Ypsomed Holding AG engages in the development and manufacture of self-injection systems and drug delivery devices for pharmaceutical and biotechnology companies. It operates through the following segment: Delivery Systems. The Delivery Systems segment consists of pen injectors, autoinjectors, and wearable on-body devices, including UnoPen, ServoPen, YpsoPen, FixPen, YpsoMate, YpsoLoop, YpsoDose, LyoTwist, and VarioJect. The company was founded by Wilhelm Michel on December 29, 2003 and is headquartered in Burgdorf, Switzerland.

Employees
2,025
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
CH0019396990
Primary Ticker
YPSN

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation